1. Home
  2. LFMD vs EOLS Comparison

LFMD vs EOLS Comparison

Compare LFMD & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LFMD
  • EOLS
  • Stock Information
  • Founded
  • LFMD 1994
  • EOLS 2012
  • Country
  • LFMD United States
  • EOLS United States
  • Employees
  • LFMD N/A
  • EOLS N/A
  • Industry
  • LFMD Medical/Nursing Services
  • EOLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • LFMD Health Care
  • EOLS Health Care
  • Exchange
  • LFMD Nasdaq
  • EOLS Nasdaq
  • Market Cap
  • LFMD 535.4M
  • EOLS 589.3M
  • IPO Year
  • LFMD N/A
  • EOLS 2018
  • Fundamental
  • Price
  • LFMD $10.55
  • EOLS $9.21
  • Analyst Decision
  • LFMD Buy
  • EOLS Strong Buy
  • Analyst Count
  • LFMD 6
  • EOLS 5
  • Target Price
  • LFMD $12.50
  • EOLS $23.75
  • AVG Volume (30 Days)
  • LFMD 1.6M
  • EOLS 768.5K
  • Earning Date
  • LFMD 08-06-2025
  • EOLS 07-30-2025
  • Dividend Yield
  • LFMD N/A
  • EOLS N/A
  • EPS Growth
  • LFMD N/A
  • EOLS N/A
  • EPS
  • LFMD N/A
  • EOLS N/A
  • Revenue
  • LFMD $234,007,330.00
  • EOLS $275,463,000.00
  • Revenue This Year
  • LFMD $29.80
  • EOLS $33.42
  • Revenue Next Year
  • LFMD $18.03
  • EOLS $33.18
  • P/E Ratio
  • LFMD N/A
  • EOLS N/A
  • Revenue Growth
  • LFMD 43.07
  • EOLS 25.38
  • 52 Week Low
  • LFMD $3.99
  • EOLS $8.67
  • 52 Week High
  • LFMD $15.84
  • EOLS $17.82
  • Technical
  • Relative Strength Index (RSI)
  • LFMD 35.90
  • EOLS 48.56
  • Support Level
  • LFMD $10.68
  • EOLS $9.12
  • Resistance Level
  • LFMD $11.47
  • EOLS $9.95
  • Average True Range (ATR)
  • LFMD 0.64
  • EOLS 0.31
  • MACD
  • LFMD -0.32
  • EOLS 0.03
  • Stochastic Oscillator
  • LFMD 0.00
  • EOLS 45.26

About LFMD LifeMD Inc.

LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: